-
1
-
-
0028075793
-
Pharmacokinetics of dibromodulcitol in children with brain tumor
-
Paál K, Schuler D, Csáki Cs, et al. Pharmacokinetics of dibromodulcitol in children with brain tumor. Anti-Cancer Drugs 1994; 5: 539-47.
-
(1994)
Anti-Cancer Drugs
, vol.5
, pp. 539-547
-
-
Paál, K.1
Schuler, D.2
Csáki, Cs.3
-
2
-
-
15144347353
-
Pre- and postoperative chemotherapy in the multimodality treatment of brain tumors in children
-
Somlo P, Borsi JD, Kisban J, et al. Pre- and postoperative chemotherapy in the multimodality treatment of brain tumors in children. Med Pediatr Oncol 1991; 19: 407.
-
(1991)
Med Pediatr Oncol
, vol.19
, pp. 407
-
-
Somlo, P.1
Borsi, J.D.2
Kisban, J.3
-
3
-
-
15144361101
-
Treatment of pediatric brain tumor patients with a multidrug chemotherapy-radiotherapy protocol containing dibromodulcitol
-
Ferencz T, Borsi JD, Paraicz E, et al. Treatment of pediatric brain tumor patients with a multidrug chemotherapy-radiotherapy protocol containing dibromodulcitol. Med Pediatr Oncol 1994; 23: 215.
-
(1994)
Med Pediatr Oncol
, vol.23
, pp. 215
-
-
Ferencz, T.1
Borsi, J.D.2
Paraicz, E.3
-
4
-
-
15144351566
-
Combination chemotherapy containing dibromodulcitol with craniospinal irradiation in the treatment of childhood central nervous system malignancies
-
Ferencz T, Csáki Cs, Paál K, et al. Combination chemotherapy containing dibromodulcitol with craniospinal irradiation in the treatment of childhood central nervous system malignancies. Med Pediatr Oncol 1995; 25: 304.
-
(1995)
Med Pediatr Oncol
, vol.25
, pp. 304
-
-
Ferencz, T.1
Csáki, Cs.2
Paál, K.3
-
5
-
-
15144345668
-
Combined adjuvant chemotherapy in malignant pediatric brain tumors - Preliminary results
-
Ferencz T, Csaki C, Paal Ch, et al. Combined adjuvant chemotherapy in malignant pediatric brain tumors - preliminary results. Med Pediatr Oncol 1997; 29: 416.
-
(1997)
Med Pediatr Oncol
, vol.29
, pp. 416
-
-
Ferencz, T.1
Csaki, C.2
Paal, Ch.3
-
7
-
-
0028149207
-
High performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid
-
Belz S, Frickel C, Wolfrom C. High performance liquid chromatographic determination of methotrexate, 7-hydroxymethotrexate, 5-methyltetrahydrofolic acid and folinic acid in serum and cerebrospinal fluid. J Chromatogr 1994; 661: 109-18.
-
(1994)
J Chromatogr
, vol.661
, pp. 109-118
-
-
Belz, S.1
Frickel, C.2
Wolfrom, C.3
-
8
-
-
0019945826
-
The protein binding and elimination of methotrexate after intravenous infusions in cancer patients
-
Paxton JW. The protein binding and elimination of methotrexate after intravenous infusions in cancer patients. Clin Exp Pharmacol Physiol 1982; 9: 225-34.
-
(1982)
Clin Exp Pharmacol Physiol
, vol.9
, pp. 225-234
-
-
Paxton, J.W.1
-
10
-
-
0021324076
-
Interaction of probenicid with the protein binding of methotrexate
-
Paxton JW. Interaction of probenicid with the protein binding of methotrexate. Pharmacology 1984; 28: 86-9.
-
(1984)
Pharmacology
, vol.28
, pp. 86-89
-
-
Paxton, J.W.1
-
11
-
-
0019433763
-
Protein binding of methotrexate in sera from normal human beings: Effect of drug-concentration, pH, temperature, and storage
-
Paxton JW. Protein binding of methotrexate in sera from normal human beings: effect of drug-concentration, pH, temperature, and storage. J Pharmacol Methods 1981; 5: 203-13.
-
(1981)
J Pharmacol Methods
, vol.5
, pp. 203-213
-
-
Paxton, J.W.1
-
12
-
-
0017411650
-
Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding
-
Taylor JR, Halprin KM. Effect of sodium salicylate and indomethacin on methotrexate-serum albumin binding. Arch Dermatol 1977; 113: 588-91.
-
(1977)
Arch Dermatol
, vol.113
, pp. 588-591
-
-
Taylor, J.R.1
Halprin, K.M.2
-
13
-
-
0021952899
-
Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenicid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro
-
Gewirtz DA, Holt SA. Protein binding as a component of drug interaction in cellular pharmacokinetic studies. Effects of probenicid on transport and accumulation of methotrexate in Ehrlich ascites tumor cells in vitro. Biochem Pharmacol 1985; 34: 747-54.
-
(1985)
Biochem Pharmacol
, vol.34
, pp. 747-754
-
-
Gewirtz, D.A.1
Holt, S.A.2
-
14
-
-
0018888518
-
Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy
-
Coassolo P, Valentin M, Bourdeaux M, Briand C. Modification of human serum albumin binding of methotrexate by folinic acid and certain drugs used in cancer chemotherapy. Eur J Clin Pharmacol 1980; 17: 123-7.
-
(1980)
Eur J Clin Pharmacol
, vol.17
, pp. 123-127
-
-
Coassolo, P.1
Valentin, M.2
Bourdeaux, M.3
Briand, C.4
-
15
-
-
0016872250
-
Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high dose methotrexate-folinic acid rescue protocols
-
Goldman ID, Gupta V, Courtland JW, Lotfield S. Exchangeable intracellular methotrexate levels in the presence and absence of vincristine at extracellular drug concentrations relevant to those achieved in high dose methotrexate-folinic acid rescue protocols. Cancer Res 1976; 36: 276-9.
-
(1976)
Cancer Res
, vol.36
, pp. 276-279
-
-
Goldman, I.D.1
Gupta, V.2
Courtland, J.W.3
Lotfield, S.4
-
17
-
-
0025169552
-
Changes in renal clearance of total and unbound etoposide in patients with liver dysfunction
-
Stewart CT, Arbuck SG, Fleming RA, Evans WE. Changes in renal clearance of total and unbound etoposide in patients with liver dysfunction. J Clin Oncol 1990; 8: 1874-9.
-
(1990)
J Clin Oncol
, vol.8
, pp. 1874-1879
-
-
Stewart, C.T.1
Arbuck, S.G.2
Fleming, R.A.3
Evans, W.E.4
-
18
-
-
0025119417
-
Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients
-
Stewart CT, Fleming RA, Arbuck SG, Evans WE. Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients. Cancer Res 1990; 50: 6854-6.
-
(1990)
Cancer Res
, vol.50
, pp. 6854-6856
-
-
Stewart, C.T.1
Fleming, R.A.2
Arbuck, S.G.3
Evans, W.E.4
-
21
-
-
0018104544
-
Comparison of uptake and binding of two epipodofillotoxin glucopyranosides, 4′-demethyl epipodofillotoxin thenylidene-beta-D-glucoside and 4-demethyl epidofillotoxin ethylene-beta-D-glucoside, in the L1210 leukemia cell
-
Allen LM. Comparison of uptake and binding of two epipodofillotoxin glucopyranosides, 4′-demethyl epipodofillotoxin thenylidene-beta-D-glucoside and 4-demethyl epidofillotoxin ethylene-beta-D-glucoside, in the L1210 leukemia cell. Cancer Res 1978; 38: 2549-54.
-
(1978)
Cancer Res
, vol.38
, pp. 2549-2554
-
-
Allen, L.M.1
-
22
-
-
0020035648
-
Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale?
-
Allen LM, Tejada F, Okonmah AD, Nordqvist S. Combination chemotherapy of the epipodophyllotoxin derivatives, teniposide and etoposide. A pharmacodynamic rationale? Cancer Chemother Pharmacol 1982; 7: 151-6.
-
(1982)
Cancer Chemother Pharmacol
, vol.7
, pp. 151-156
-
-
Allen, L.M.1
Tejada, F.2
Okonmah, A.D.3
Nordqvist, S.4
|